[Systemic effects of ophthalmic solutions].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced; D004058:Diffusion; D005128:Eye Diseases / Q000188:drug therapy; D006402:Hematologic Diseases / Q000139:chemically induced; D009184:Mydriatics / Q000009:adverse effects; D009422:Nervous System Diseases / Q000139:chemically induced; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects; D013999:Timolol / Q000009:adverse effects / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D009184:Mydriatics; D009883:Ophthalmic Solutions; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013449:Sulfonamides; D013566:Sympathomimetics; D013999:Timolol
Effets systémiques des collyres.